Veru Inc. is an oncology and urology biopharmaceutical company developing and commercializing novel medicines for the prostate cancer continuum of care and urology specialty pharmaceuticals.
August 8, 2019
Listen to the replay of our latest earnings conference call.
Listen to other presentations and conference calls
September 11, 2019
View Slide Deck
We’re looking forward to presenting at the upcoming 2018 Jefferies Healthcare Conference Presentation. As soon as the conference starts, the link will be available. See you there!
August 28, 2019
Veru to Participate at Three Upcoming Healthcare Investor Conferences in New York
August 27, 2019
Veru to Ring NASDAQ Closing Bell on September 4th to Kick Off National Prostate Cancer Awareness Month